AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 72 filers reported holding AMYLYX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,623,227 | -15.1% | 853,262 | 0.0% | 9.88% | -18.1% |
| Q2 2023 | $18,404,861 | -32.6% | 853,262 | -8.3% | 12.06% | +19.7% |
| Q1 2023 | $27,296,088 | -10.0% | 930,337 | +13.3% | 10.08% | +81.8% |
| Q4 2022 | $30,344,079 | +53.9% | 821,220 | +17.2% | 5.54% | +137.7% |
| Q3 2022 | $19,723,000 | +46.2% | 700,635 | 0.0% | 2.33% | +67.9% |
| Q2 2022 | $13,494,000 | +70.1% | 700,635 | +13.5% | 1.39% | +94.1% |
| Q1 2022 | $7,931,000 | – | 617,220 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,088,333 | $224,963,904 | 6.32% |
| Alpha Wave Global, LP | 821,220 | $30,344,079 | 5.54% |
| Ghost Tree Capital, LLC | 350,000 | $12,933,000 | 5.52% |
| Boxer Capital, LLC | 2,084,000 | $77,003,800 | 4.06% |
| Altium Capital Management LP | 140,000 | $5,173,000 | 2.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,693,000 | $99,506,350 | 2.06% |
| Iron Triangle Partners LP | 240,240 | $8,876,868 | 1.59% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 655,015 | $24,202,804 | 1.50% |
| EMERALD ADVISERS, LLC | 836,909 | $30,923,788 | 1.49% |
| GREAT POINT PARTNERS LLC | 190,000 | $7,020,500 | 1.38% |